Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer

by Tarah J. Ballinger, Jason B. Meier, Valerie M. Jansen
Published 2018-08-01

A Personalized, Dynamic Physical Activity Intervention Is Feasible and Improves Energetic Capacity, Energy Expenditure, and Quality of Life in Breast Cancer Survivors

by Tarah J. Ballinger, Sandra K. Althouse, Timothy P. Olsen, Kathy D. Miller, Jeffrey S. Sledge
Published 2021-04-01

Evaluation of an Extended-duration Chemoprophylaxis Regimen for Venous Thromboembolism after Microsurgical Breast Reconstruction

by Eric M. Pittelkow, MD, Will C. DeBrock, MD, Brian Mailey, MD, Tarah J. Ballinger, MD, Juan Socas, MD, Mary E. Lester, MD, Aladdin H. Hassanein, MD, MMSc
Published 2021-08-01